Wednesday, 16 December 2015

In Price-Gouging Investigation, Oversight Committee Calls For Generic-Drug Information From FDA

And Rep. Elijah Cummings, the ranking Democrat on the committee, is keeping the pressure on Valeant Pharmaceuticals. The Maryland lawmaker is asking for witnesses and documents from the CEO by Jan. 8.

No comments:

Post a Comment